Jump Financial, LLC

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1831577 Chicago, IL

Position in SNDX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,806,213

+$5,362,359 QoQ

Shares Held

402,846

+145.8% QoQ

Ownership

0.451%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#51

of 242 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. SNDX ranks #9 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,806,213	402,846	+145.8%	Shares	Defined	2026-08-13
2025-12-31	$3,443,854	163,915	+23.5%	Shares	Defined	2026-02-17
2025-09-30	$2,041,604	132,701	-65.2%	Shares	Defined	2025-11-13
2025-06-30	$3,568,391	381,035	+119.1%	Shares	Defined	2025-08-13
2024-12-31	$2,298,825	173,890	+80.8%	Shares	Defined	2025-02-13
2024-09-30	$1,851,676	96,191	+156.5%	Shares	Defined	2024-11-14
2024-06-30	$769,875	37,500	-75.8%	Shares	Defined	2024-11-14
2023-09-30	$2,247,492	154,786	+326.6%	Shares	Sole	2024-10-21
2023-06-30	$759,465	36,286	-13.2%	Shares	Sole	2024-10-21
2022-03-31	$726,484	41,800	-24.8%	Shares	Sole	2022-05-12
2021-12-31	$1,217,368	55,613	+247.3%	Shares	Sole	2022-02-10
2020-12-31	$356,084	16,011	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.